Avricore Health (AVCRF) Return on Invested Capital (2013 - 2025)

Avricore Health has disclosed Return on Invested Capital across 9 years of filings, most recently posting 0.0% for Q3 2025.

• In Q3 2025, Return on Invested Capital fell 1.0% year-over-year to 0.0%; the TTM figure through Sep 2025 stood at 0.0% (down 1.0% YoY), while the FY2024 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital fell to 0.0% in Q3 2025, from 0.0% in the prior quarter.
• Over the last five years, Return on Invested Capital for AVCRF reached as high as 0.01% in Q4 2021 and fell as low as 0.02% in Q3 2021.
• The 5-year median for Return on Invested Capital is 0.01% (2022), against an average of 0.0%.
• The widest YoY moves for Return on Invested Capital: up 29 bps in 2021, down 16 bps in 2021.
• A 5-year view of Return on Invested Capital shows it stood at 0.01% in 2021, then sank by 69 bps to 0.0% in 2022, then grew by 5 bps to 0.0% in 2023, then jumped by 115 bps to 0.01% in 2024, then slumped by 107 bps to 0.0% in 2025.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.01% for Q3 2025, Q2 2025, and Q1 2025 respectively.